Strs Ohio Blueprint Medicines Corp Transaction History

Strs Ohio

$25.8 Billion
Q2 2025

A detailed history of Strs Ohio transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Strs Ohio holds 8,300 shares of BPMC stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,300

Previous 6,700 23.88%

Holding current value

$1.07 Million

Previous $593,000 79.26%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	BUY	$79.22 - $128.4 $126,752 - $205,440	1,600 Added 23.88%	8,300 $1.06 Million
Q1 2025 May 28, 2025	BUY	$86.69 - $115.63 $43,345 - $57,815	500 Added 8.06%	6,700 $593,000
Q4 2024 May 28, 2025	SELL	$82.48 - $101.39 $16,496 - $20,278	-200 Reduced 2.99%	6,500 $566,000
Q3 2024 Nov 01, 2024	SELL	$84.1 - $120.5 $109,329 - $156,650	-1,300 Reduced 17.33%	6,200 $573,000
Q2 2024 Aug 05, 2024	BUY	$85.18 - $108.78 $153,324 - $195,804	1,800 Added 31.58%	7,500 $808,000
Q1 2024 May 13, 2024	SELL	$73.17 - $99.79 $80,487 - $109,769	-1,100 Reduced 16.18%	5,700 $540,000
Q4 2023 Jan 30, 2024	BUY	$43.96 - $92.84 $145,068 - $306,372	3,300 Added 94.29%	6,800 $627,000
Q3 2023 Oct 26, 2023	SELL	$46.9 - $66.0 $65,660 - $92,400	-1,400 Reduced 28.57%	3,500 $175,000
Q2 2023 Jul 31, 2023	BUY	$42.2 - $66.37 $113,940 - $179,199	2,700 Added 122.73%	4,900 $309,000
Q1 2023 Aug 02, 2023	SELL	$37.97 - $50.0 $102,519 - $135,000	-2,700 Reduced 55.1%	2,200 $98,000
Q1 2023 Apr 27, 2023	BUY	$37.97 - $50.0 $11,391 - $15,000	300 Added 15.79%	2,200 $98,000
Q4 2022 Jan 26, 2023	SELL	$41.06 - $66.48 $164,240 - $265,920	-4,000 Reduced 67.8%	1,900 $83,000
Q3 2022 Oct 27, 2022	BUY	$49.93 - $77.7 $94,867 - $147,630	1,900 Added 47.5%	5,900 $388,000
Q2 2022 Jul 25, 2022	SELL	$45.23 - $70.15 $131,167 - $203,435	-2,900 Reduced 42.03%	4,000 $202,000
Q4 2021 Jan 24, 2022	SELL	$94.25 - $115.99 $65,975 - $81,193	-700 Reduced 9.21%	6,900 $739,000
Q3 2021 Oct 22, 2021	SELL	$80.98 - $109.47 $64,784 - $87,576	-800 Reduced 9.52%	7,600 $781,000
Q2 2021 Jul 26, 2021	BUY	$82.78 - $101.0 $66,224 - $80,800	800 Added 10.53%	8,400 $738,000
Q1 2021 Apr 23, 2021	SELL	$90.71 - $108.28 $653,112 - $779,616	-7,200 Reduced 48.65%	7,600 $738,000
Q4 2020 Jan 25, 2021	BUY	$92.08 - $124.48 $699,808 - $946,048	7,600 Added 105.56%	14,800 $1.66 Million
Q3 2020 Dec 14, 2020	SELL	$66.45 - $92.7 $66,450 - $92,700	-1,000 Reduced 12.2%	7,200 $667,000
Q2 2020 Jul 23, 2020	BUY	$57.09 - $79.27 $34,254 - $47,562	600 Added 7.89%	8,200 $639,000
Q1 2020 Apr 23, 2020	BUY	$48.11 - $82.22 $96,220 - $164,440	2,000 Added 35.71%	7,600 $444,000
Q4 2019 Jan 24, 2020	SELL	$66.73 - $82.59 $120,114 - $148,662	-1,800 Reduced 24.32%	5,600 $448,000
Q2 2019 Jul 25, 2019	BUY	$73.54 - $97.8 $205,912 - $273,840	2,800 Added 60.87%	7,400 $698,000
Q1 2019 Apr 19, 2019	BUY	$48.7 - $86.6 $73,050 - $129,899	1,500 Added 48.39%	4,600 $368,000
Q4 2018 Jan 23, 2019	SELL	$45.57 - $74.26 $13,671 - $22,278	-300 Reduced 8.82%	3,100 $167,000
Q3 2018 Oct 19, 2018	SELL	$58.91 - $78.32 $182,621 - $242,791	-3,100 Reduced 47.69%	3,400 $265,000
Q2 2018 Aug 06, 2018	BUY	$60.96 - $101.18 $36,576 - $60,708	600 Added 10.17%	6,500 $412,000
Q1 2018 Apr 20, 2018	BUY	$73.28 - $102.95 $146,560 - $205,900	2,000 Added 51.28%	5,900 $541,000
Q4 2017 Jan 23, 2018	BUY	$62.91 - $88.32 $100,656 - $141,312	1,600 Added 69.57%	3,900 $294,000
Q3 2017 Oct 23, 2017	BUY	$42.37 - $69.67 $97,451 - $160,241	2,300	2,300 $160,000

Others Institutions Holding BPMC

# of Institutions

389

Shares Held

66.9M

Call Options Held

973K

Put Options Held

1.54M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.73B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account